Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2026-08-31 | Reverse | 1:30 |
Nexalin Technology, Inc. develops non-invasive neurostimulation devices for mental health treatment, including anxiety, insomnia, and other disorders, with products marketed in the U.S. and China.

The Gen-3 HALO Clarity is a non-invasive, at-home neurostimulation headset that delivers proprietary waveforms to deep brain areas for drug-free mental health treatment, supporting Nexalin's virtual clinic model with remote monitoring and personal...
| Icon | PRODUCT | Q4-2024 | Q1-2025 | Q2-2025 | Q4-2025 |
|---|---|---|---|---|---|
![]() | Licensing Fee | $31K | $17.31K ▼ | $10.36K ▼ | $31.8K ▲ |
![]() | Equipment | $17.51K | $19.81K ▲ | $52.53K ▲ | $16.7K ▼ |
![]() | Other | $5.51K | $3.89K ▼ | $7.71K ▲ | $15.89K ▲ |
![]() | Device Sales | $0 | — | — | — |
| Map | REGION | Q1-2025 | Q2-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|---|
![]() | CHINA | $20.57K | $59.48K ▲ | $110.25K ▲ | — |
![]() | UNITED STATES | $20.44K | $11.11K ▼ | $79.79K ▲ | $14.95K ▼ |
Overall rating: D+
| PEER | PRICE | |
|---|---|---|
NRXS | $6.00 | COMPARE |
HBIO | $7.93 | COMPARE |
SCYX | $5.39 | COMPARE |
ENLV | $1.35 | COMPARE |
XCUR | $1.29 | COMPARE |
MODD | $3.46 | COMPARE |
CLGN | $0.36 | COMPARE |
RBOT | $0.04 | COMPARE |